Maternal high-dose folic acid during pregnancy and asthma medication in the offspring

Pharmacoepidemiology and Drug Safety

Volumn 23, Issue 10, 2014, Pages 1059-1065

  Zetstra van der Woude, Priscilla A ^a   De Walle, Hermien E K ^b   Hoek, Annemieke ^b   Bos, H Jens ^a   Boezen, H Marike ^b   Koppelman, Gerhard H ^b,c   de Jong van den Berg, Lolkje T W ^a   Scholtens, Salome ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Childhood asthma; Folic acid; Guidelines; Pharmacoepidemiology; Pregnancy

Indexed keywords

ANTIASTHMATIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CORTICOSTEROID; FOLIC ACID;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; EPIDEMIOLOGICAL DATA; FACTUAL DATABASE; FEMALE; FIRST TRIMESTER PREGNANCY; HIGH RISK POPULATION; HUMAN; INCIDENCE RATE RATIO; MALE; MATERNAL AGE; MATERNAL EXPOSURE; MEDICAL INFORMATION; NETHERLANDS; PHARMACY DISPENSING DATA; PREGNANT WOMAN; PRESCRIPTION; PROGENY; RISK FACTOR; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; ADVERSE EFFECTS; CHEMICALLY INDUCED; CHILD; DOSE RESPONSE; DRUG USE; ENVIRONMENTAL EXPOSURE; PHARMACY; PREGNANCY; PRENATAL EXPOSURE; PREVALENCE; STATISTICS AND NUMERICAL DATA;

ASTHMA; CHILD; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; FOLIC ACID; HUMANS; MALE; MATERNAL EXPOSURE; NETHERLANDS; PHARMACIES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE;

EID: 84911806861     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3652     Document Type: Article

References (35)

1. Czeizel AE. Periconceptional folic acid and multivitamin supplementation for the prevention of neural tube defects and other congenital abnormalities. Birth Defects Res A Clin Mol Teratol 2009; 85: 260-268. doi:10.1002/bdra.20563.
2. van Beynum IM, Kapusta L, Bakker MK, et al. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the Northern Netherlands. Eur Heart J 2010; 31: 464-471. doi:10.1093/eurheartj/ehp479.
3. Lucock M, Yates Z. Folic acid-vitamin and panacea or genetic time bomb? Nat Rev Genet 2005; 6: 235-240. doi:10.1038/nrg1558.
4. Muskiet FA, Kemperman RF. Folate and long-chain polyunsaturated fatty acids in psychiatric disease. J Nutr Biochem 2006; 17: 717-727. doi:10.1016/j.jnutbio.2006.02.001.
5. Yajnik CS, Deshpande SS, Jackson AA, et al. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 2008; 51: 29-38. doi:10.1007/s00125-007-0793-y.
6. Burdge GC, Lillycrop KA. Folic acid supplementation in pregnancy: are there devils in the detail? Br J Nutr 2012; 108: 1924-1930. doi:10.1017/S0007114512003765.
7. Haberg SE, London SJ, Stigum H, et al. Folic acid supplements in pregnancy and early childhood respiratory health. Arch Dis Child 2009; 94: 180-184. doi:10.1136/adc.2008.142448.
8. Granell R, Heron J, Lewis S, et al. The association between mother and child MTHFR C677T polymorphisms, dietary folate intake and childhood atopy in a population-based, longitudinal birth cohort. Clin Exp Allergy 2008; 38: 320-328. doi:10.1111/j.1365-2222.2007.02902.x.
9. Whitrow MJ, Moore VM, Rumbold AR, et al. Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. Am J Epidemiol 2009; 170: 1486-1493. doi:10.1093/aje/kwp315.
10. Magdelijns FJ, Mommers M, Penders J, et al. Folic acid use in pregnancy and the development of atopy, asthma, and lung function in childhood. Pediatrics 2011; 128: e135-e144. doi:10.1542/peds.2010-1690.
11. Miyake Y, Sasaki S, Tanaka K, et al. Maternal B vitamin intake during pregnancy and wheeze and eczema in Japanese infants aged 16-24 months: the Osaka Maternal and Child Health Study. Pediatr Allergy Immunol 2011; 22: 69-74. doi:10.1111/j.1399-3038.2010.01081.x.
12. Bekkers MB, Elstgeest LE, Scholtens S, et al. Maternal use of folic acid supplements during pregnancy and childhood respiratory health and atopy: the PIAMA birth cohort study. Eur Respir J 2012; 39: 1468-1474. doi:10.1183/09031936.00094511.
13. Hollingsworth JW, Maruoka S, Boon K, et al. In utero supplementation with methyl donors enhances allergic airway disease in mice. J Clin Invest 2008; 118: 3462-3469. doi:10.1172/JCI34378.
14. Blom HJ, Smulders Y. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J Inherit Metab Dis 2011; 34: 75-81. doi:10.1007/s10545-010-9177-4.
15. Cheschier N. ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin. Neural tube defects. Number 44, July 2003. (Replaces committee opinion number 252, March 2001). Int J Gynaecol Obstet 2003; 83(1): 123-133. doi:10.1016/S0020-7292(03)00390-4.
16. De Jong-Potjer LC, Beentjes M, Bogchelman M, et al. NHG standard 'Preconception care'. Huisarts Wet 2011; 54: 310-326.
17. Pena-Rosas JP, Viteri FE. Effects and safety of preventive oral iron or iron + folic acid supplementation for women during pregnancy. Cochrane Database Syst Rev 2009; CD004736. DOI: 10.1002/14651858.CD004736.pub3
18. Wilson RD, Johnson JA, Wyatt P, et al. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2007; 29: 1003-1026.
19. Bakker MK, de Walle HEK, Dequito A, et al. Selection of controls in case-control studies on maternal medication use and risk of birth defects. Birth Defects Res A Clin Mol Teratol 2007; 79: 652-656. doi:10.1002/bdra.20388.
20. Monster TB, Janssen WM, de Jong PE, et al. Pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Saf 2002; 11: 379-384. doi:10.1002/pds.722.
21. Nijenhuis CM, Horst PG, Rein N, et al. Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: testing the hypotheses. Br J Clin Pharmacol 2012; 73: 126-134. doi:10.1111/j.1365-2125.2011.04081.x.
22. Schirm E, Tobi H, de Jong-van den Berg LTW. Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children. J Clin Epidemiol 2004; 57: 737-741. doi:10.1016/j.jclinepi.2002.12.001.
23. Ter Horst PG, Bos HJ, de Jong-van den Berg LTW, et al. In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children. Eur J Clin Pharmacol 2013; 69: 541-547. doi:10.1007/s00228-012-1314-6.
24. Acutele cijfers aangeboren aandoeningen Eurocat Nederland (current figures congenital malformations). Available at http://www.rug.nl/research/genetics/eurocat/. (Accessed 2 May 2012) (In Dutch).
25. Annesi-Maesano I, Moreau D, Strachan D. In utero and perinatal complications preceding asthma. Allergy 2001; 56: 491-497. doi:10.1034/j.1398-9995.2001.056006491.x.
26. Smith AM, Picciano MF, Deering RH. Folate supplementation during lactation: maternal folate status, human milk folate content, and their relationship to infant folate status. J Pediatr Gastroenterol Nutr 1983; 2: 622-628.
27. Houghton LA, Yang J, O'Connor DL. Unmetabolized folic acid and total folate concentrations in breast milk are unaffected by low-dose folate supplements. Am J Clin Nutr 2009; 89: 216-220. doi:10.3945/ajcn.2008.26564.
28. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007; 447: 425-432. doi:10.1038/nature05918.
29. Martino DJ, Prescott SL. Silent mysteries: epigenetic paradigms could hold the key to conquering the epidemic of allergy and immune disease. Allergy 2010; 65: 7-15. doi:10.1111/j.1398-9995.2009.02186.x.
30. Koppelman GH, Nawijn MC. Recent advances in the epigenetics and genomics of asthma. Curr Opin Allergy Clin Immunol 2011; 11: 414-419. doi:10.1097/ACI.0b013e32834a9573.
31. Steegers-Theunissen RP, Obermann-Borst SA, Kremer D, et al. Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS One 2009; 4: e7845. doi:10.1371/journal.pone.0007845.
32. Zetstra-van der Woude PA, Walle HEK, de Jong-van den Berg LTW. Periconceptional folic acid use: still room to improve. Birth Defects Res A Clin Mol Teratol 2012; 94: 96-101. doi:10.1002/bdra.22882.
33. Gezondheidsraad/Voedingsraad. Vervolgadvies inzake foliumzuurvoorziening in relatie tot neuraalbuisdefecten. (Additional advice concerning folic acid intake in respect of neural tube defects.) The Hague: Voorlichtingsbureau voor de Voeding, 1993 (in Dutch).
34. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the MRC Vitamin Study. Lancet 1991; 338: 131-137.
35. Kennedy D, Koren G. Identifying women who might benefit from higher doses of folic acid in pregnancy. Can Fam Physician 2012; 58: 394-397.